Genes & Diseases

Open access

ISSN: 2352-3042
CN: 50-1221/R
p-ISSN: 2352-4820

Genes & Diseases

Open access

About the JournalGenes & Diseases is a journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeu...

About the Journal

Genes & Diseases is a journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.

Aims and Scopes

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis will be placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.

Society affiliation

Chongqing Medical University (CQMU), originally known as Chongqing Medical College, was founded in 1956, growing out of Shanghai First Medical College (the present Shanghai Medical College of Fudan University). With over 60 years' development, CQMU has grown into a state-funded medical university with an integrated educational system of Bachelo...

Chongqing Medical University (CQMU), originally known as Chongqing Medical College, was founded in 1956, growing out of Shanghai First Medical College (the present Shanghai Medical College of Fudan University). With over 60 years' development, CQMU has grown into a state-funded medical university with an integrated educational system of Bachelor's, Master's, Doctor's and Postdoctoral programs in medicine as well as other related fields.
CQMU currently has more than 3,200 faculty members, including Academicians of the Chinese Academy of Engineering, Chief Scientists of the National 973 Program, and Changjiang Scholars. CQMU has 4 State key discipline (Clinical Laboratory Diagnostics, Pediatrics, Infectious Disease, and Neurology), 4 First-class discipline (Clinical Medicine, Pharmacy, Basic Medicine, and Bioengineering), and 5 State-level Research Platforms. CQMU has taken the lead in undertaking the National Basic Research Program (973 Program), National High-Tech Research and Development Program (863 Program) and the Key Program of National Natural Science Foundation.
CQMU has established contacts and cooperative relationships with 52 institutions from 23 countries and regions, including University of Leicester, University College London of the United Kingdom, University of British Columbia of Canada and Dartmouth College of the United States, for staff training, exchange of students, academic exchanges and scientific research.
In the 60 years since its establishment, CQMU has made outstanding achievements in personnel training, scientific research and medical services, and has made important contributions to the development of medical education and health services in China, as well as to the local economic construction.

Systematic pan-cancer analysis reveals OGT and OGA as potential biomarkers for tumor microenvironment and therapeutic responses

SARS-CoV-2 triggers Dickkopf-1 (Dkk-1) modulation of T helper cells and lung pathology in mice

Comprehensive characterization of cell disulfidptosis in human cancers: An integrated pan-cancer analysis

View all ScienceDirect

1. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

2. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

3. Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy

View all ScienceDirect

Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases

Advances in the early diagnosis of hepatocellular carcinoma

View all Scopus

News

View all

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.